Brightbulb/Chuckles/Bumblebead100% agree with everything you had to say Brightbulb. This will be a package deal. Either after phase I, or after phase II.
You used a great analogy about product management.
Based on the information GAP has collected thus far (really take a look at that), the amount of risk involved in getting approved for trials, and getting through phase I isn't as significant as some may believe. Hence why they are taking it that far, and how it's like using a golf ball to hit the home run instead of a baseball.
Delays continue to happen in getting testing done, peptide delivered, etc, that's why the "steady stream" has turned into a few drops dribbling by. Should be an update at some point on all the upcoming tests that are underway and some results coming in.
You are right, Bryden stirs this drink. I will be perfectly open that I am one of many who are trying to get Bob out of there. I do think he is a great guy personally, but business is business and he is the face of all the delays that has happened over the years, and it's time for a change.
Chuckles, Martin has never left GAP and still is in the same role.
Bumble, I really have no problem with you disagreeing with me, I just ask you give some kind of rationale on why you think this is going lower other then stating....this is going LOWER....end of sentence.